skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 72,833  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
S1154 Direct-Acting Oral Anticoagulant and Warfarin Use in Patients With Advanced Cirrhosis
Material Type:
Article
Add to My Research

S1154 Direct-Acting Oral Anticoagulant and Warfarin Use in Patients With Advanced Cirrhosis

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S540-S540 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000778148.88105.39

Full text available

2
Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
Material Type:
Article
Add to My Research

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

PloS one, 2020-06, Vol.15 (6), p.e0234298-e0234298 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Boon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Boon et al 2020 Boon et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0234298 ;PMID: 32484829

Full text available

3
First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in PatientsReceiving Xabans
Material Type:
Article
Add to My Research

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in PatientsReceiving Xabans

Clinical and applied thrombosis/hemostasis, 2018-09, Vol.24 (6), p.914-919 [Peer Reviewed Journal]

The Author(s) 2017. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1076-0296 ;EISSN: 1938-2723 ;DOI: 10.1177/1076029617734310

Full text available

4
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Material Type:
Article
Add to My Research

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

New England Journal of Medicine, 2021-08, Vol.385 (9), p.777-789 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2103417 ;PMID: 34351722

Digital Resources/Online E-Resources

5
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Material Type:
Article
Add to My Research

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

New England Journal of Medicine, 2021-08, Vol.385 (9), p.790-802 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2105911 ;PMID: 34351721

Digital Resources/Online E-Resources

6
Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
Material Type:
Article
Add to My Research

Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis

European journal of vascular and endovascular surgery, 2021, Vol.61 (1), p.9 [Peer Reviewed Journal]

ISSN: 1532-2165 ;EISSN: 1532-2165 ;DOI: 10.1016/j.ejvs.2020.09.023

Digital Resources/Online E-Resources

7
Reversal of the Target Specific Oral Anticoagulants: A Practical Approach to a Situation With Incomplete Information
Material Type:
Article
Add to My Research

Reversal of the Target Specific Oral Anticoagulants: A Practical Approach to a Situation With Incomplete Information

American journal of clinical pathology, 2014-10, Vol.142 (suppl_1), p.A009-A009 [Peer Reviewed Journal]

American Society for Clinical Pathology 2015 ;American Society for Clinical Pathology ;ISSN: 0002-9173 ;EISSN: 1943-7722 ;DOI: 10.1093/ajcp/142.suppl1.009

Full text available

8
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Material Type:
Article
Add to My Research

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

BMJ (Online), 2017-11, Vol.359, p.j5058 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2017BMJThis is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See:http://creativecommons.org/licenses/by/4.0/. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2017 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.j5058 ;PMID: 29183961

Full text available

9
4CPS-016 Clinical investigation of adverse drug reactions in the treatment with non-vitamin K oral anticoagulants
Material Type:
Article
Add to My Research

4CPS-016 Clinical investigation of adverse drug reactions in the treatment with non-vitamin K oral anticoagulants

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A74-A75 [Peer Reviewed Journal]

2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2019-eahpconf.165

Full text available

10
5PSQ-013 Prescriptions of direct oral anticoagulants in patients admitted
Material Type:
Article
Add to My Research

5PSQ-013 Prescriptions of direct oral anticoagulants in patients admitted

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A207-A207 [Peer Reviewed Journal]

2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2019-eahpconf.446

Full text available

11
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Material Type:
Article
Add to My Research

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

Clinical pharmacokinetics, 2019-10, Vol.58 (10), p.1265-1279 [Peer Reviewed Journal]

The Author(s) 2019 ;Copyright Springer Nature B.V. Oct 2019 ;ISSN: 0312-5963 ;EISSN: 1179-1926 ;DOI: 10.1007/s40262-019-00775-z ;PMID: 31089975

Full text available

12
Reversal of Direct Oral Anticoagulants
Material Type:
Article
Add to My Research

Reversal of Direct Oral Anticoagulants

NEJM journal watch. Oncology & hematology, 2019-05

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 2330-0426

Full text available

13
Andexanet for Major Hemorrhage in Patients on Factor Xa Inhibitors
Material Type:
Article
Add to My Research

Andexanet for Major Hemorrhage in Patients on Factor Xa Inhibitors

NEJM journal watch. Oncology & hematology, 2019-02

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 2330-0426

Full text available

14
S3539 ANCA-Associated Leukocytoclastic Vasculitis With Mesenteric Involvement
Material Type:
Article
Add to My Research

S3539 ANCA-Associated Leukocytoclastic Vasculitis With Mesenteric Involvement

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e2221-e2222 [Peer Reviewed Journal]

2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000870796.51499.4d

Full text available

15
S679 Incidence of Major Gastrointestinal Bleeding in Veterans Taking Apixaban vs Rivaroxaban
Material Type:
Article
Add to My Research

S679 Incidence of Major Gastrointestinal Bleeding in Veterans Taking Apixaban vs Rivaroxaban

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e471-e471 [Peer Reviewed Journal]

2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000859356.44001.86

Full text available

16
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Material Type:
Article
Add to My Research

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Europace (London, England), 2015-10, Vol.17 (10), p.1467-1507 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com. ;ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euv309 ;PMID: 26324838

Full text available

17
Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
Material Type:
Article
Add to My Research

Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials

European heart journal, 2019-12, Vol.40 (46), p.3757-3767 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz732 ;PMID: 31651946

Full text available

18
Erysipelas of the lower limb: study of 400 cases
Material Type:
Article
Add to My Research

Erysipelas of the lower limb: study of 400 cases

Nasza dermatologia online, 2017-11, Vol.8 (Suppl. 1), p.15-19

Copyright Our Dermatology Online Nov 2017 ;ISSN: 2081-9390 ;EISSN: 2081-9390 ;DOI: 10.7241/ourd.2017s.4

Full text available

19
Cost effectiveness of dabigatran: value of real-world data
Material Type:
Article
Add to My Research

Cost effectiveness of dabigatran: value of real-world data

PharmacoEconomics & outcomes news, 2019-11 (840), p.9-9

Copyright Springer Nature B.V. Nov 2, 2019 ;ISSN: 1173-5503 ;EISSN: 1179-2043

Full text available

20
Edoxaban 'plausible alternative to warfarin' to treat AF after TAVR
Material Type:
Article
Add to My Research

Edoxaban 'plausible alternative to warfarin' to treat AF after TAVR

Cardiology Today, 2021-10, Vol.24 (10), p.20-20 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Oct 2021 ;ISSN: 1939-098X

Full text available

Results 1 - 20 of 72,833  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (63,240)

Refine My Results

Creation Date 

From To
  1. Before 1962  (775)
  2. 1962 To 1976  (1,674)
  3. 1977 To 1991  (2,690)
  4. 1992 To 2007  (15,468)
  5. After 2007  (52,245)
  6. More options open sub menu

Language 

  1. English  (70,113)
  2. Japanese  (5,806)
  3. German  (772)
  4. French  (749)
  5. Spanish  (646)
  6. Portuguese  (630)
  7. Russian  (417)
  8. Turkish  (153)
  9. Norwegian  (145)
  10. Swedish  (125)
  11. Korean  (108)
  12. Chinese  (106)
  13. Polish  (98)
  14. Italian  (94)
  15. Croatian  (34)
  16. Ukrainian  (21)
  17. Catalan  (19)
  18. Serbian  (16)
  19. Czech  (12)
  20. Romanian  (12)
  21. More options open sub menu

Searching Remote Databases, Please Wait